{"id":527898,"date":"2026-07-06T13:15:10","date_gmt":"2026-07-06T13:15:10","guid":{"rendered":"https:\/\/www.newsbeep.com\/il\/527898\/"},"modified":"2026-07-06T13:15:10","modified_gmt":"2026-07-06T13:15:10","slug":"sequencing-car-t-cell-therapy-and-bispecific-antibodies-in-relapsed-refractory-multiple-myeloma","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/il\/527898\/","title":{"rendered":"Sequencing CAR T-Cell Therapy and Bispecific Antibodies in Relapsed\/Refractory Multiple Myeloma"},"content":{"rendered":"\n<p class=\"\">Dr. Binod Dhakal leads a discussion on the increasingly complex treatment landscape of relapsed\/refractory multiple myeloma (RRMM), focusing on how clinicians navigate sequencing decisions among BCMA-directed therapies, including CAR T-cell therapy and bispecific antibodies.<\/p>\n<p class=\"\">Dr. Carol Ann Huff emphasizes that treatment selection is highly individualized and depends on factors such as disease aggressiveness, prior therapies, remission duration, treatment eligibility, and regulatory considerations.<\/p>\n<p class=\"\">She notes that while BCMA-targeted approaches have demonstrated significant clinical benefit, not every patient requires immediate escalation to these therapies.<\/p>\n<p class=\"\">Dr. Prerna Mewawalla further highlights the importance of disease kinetics, patient fitness, logistical considerations, access to treatment centers, and patient preferences when deciding between CAR T-cell therapy and bispecific antibodies.<\/p>\n<p class=\"\">The panel underscores the value of shared decision-making and comprehensive patient assessment, illustrating how clinical, logistical, and personal factors collectively influence sequencing strategies in the evolving RRMM treatment landscape.<\/p>\n","protected":false},"excerpt":{"rendered":"Dr. Binod Dhakal leads a discussion on the increasingly complex treatment landscape of relapsed\/refractory multiple myeloma (RRMM), focusing&hellip;\n","protected":false},"author":2,"featured_media":527899,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[114,85,46],"class_list":["post-527898","post","type-post","status-publish","format-standard","has-post-thumbnail","category-business","tag-business","tag-il","tag-israel"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/posts\/527898","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/comments?post=527898"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/posts\/527898\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/media\/527899"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/media?parent=527898"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/categories?post=527898"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/tags?post=527898"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}